Interpace Biosciences, Inc. Share Price
Stocks
IDXG
US46062X3035
Healthcare Facilities & Services
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.600 USD | -3.03% |
|
-4.19% | +30.06% |
| Market Cap | 45.71M 39.48M 36.38M 34.05M 63.81M 4.34B 64.8M 430M 167M 2.11B 172M 168M 7.32B | P/E Ratio 2024 |
6.84x | P/E Ratio 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 44.38M 38.33M 35.33M 33.07M 61.97M 4.22B 62.93M 417M 163M 2.05B 167M 163M 7.11B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
14.74% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -3.03% | ||
| 1 week | -4.19% | ||
| Current month | -5.88% | ||
| 1 month | -20.00% | ||
| 3 months | -8.05% | ||
| 6 months | +14.29% | ||
| Current year | +30.06% |
| 1 week | 1.57 |  | 1.79 |
| 1 month | 1.57 | | 2.05 |
| Current year | 1.03 | | 2.4 |
| 1 year | 0.7 | | 2.4 |
| 3 years | 0.44 | | 3.54 |
| 5 years | 0.44 | | 10.51 |
| 10 years | 0.44 | | 198 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 63 | 30/11/2020 |
| Director of Finance/CFO | 34 | 20/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 78 | 20/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 31/12/2015 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 21/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 01-19 | 1315 Capital LLC
| Conversion | Company | 9,405,941 | 212.3938% | |
| 01-19 | Ampersand Management LLC
| Conversion | Company | 13,861,386 | 313.0013% | |
| 31/01/24 | Free | Chief Financial Officer | 10,000 | 0.2314% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.03% | -4.19% | +128.54% | +39.13% | 45.71M | |
| -3.19% | -1.02% | +29.67% | +330.81% | 31.4B | |
| -0.37% | -0.21% | +1.12% | +17.83% | 21.75B | |
| -0.39% | +5.98% | -24.20% | -42.19% | 7.01B | |
| -0.78% | +7.07% | +2.83% | +78.96% | 4.58B | |
| +0.50% | +2.58% | +7.30% | +63.78% | 2.78B | |
| +0.60% | +17.88% | -7.27% | +811.78% | 1.81B | |
| +7.35% | +5.16% | -14.51% | -65.46% | 1.61B | |
| 0.00% | +3.05% | +17.65% | -2.21% | 1.6B | |
| +18.01% | +16.89% | +33.45% | -22.57% | 1.51B | |
| Average | +1.87% | +6.12% | +17.46% | +120.99% | 7.41B | |
| Weighted average by Cap. | -0.98% | +2.16% | +11.71% | +166.62% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 40.53M 37.35M 34.96M 65.52M 4.46B 66.53M 441M 172M 2.17B 176M 172M 7.52B | 38.73M 33.45M 30.82M 28.85M 54.07M 3.68B 54.91M 364M 142M 1.79B 145M 142M 6.2B |
| Net income | 6.7M 5.79M 5.33M 4.99M 9.36M 637M 9.5M 62.98M 24.56M 310M 25.15M 24.62M 1.07B | 24.58M 21.23M 19.56M 18.31M 34.31M 2.34B 34.84M 231M 90.05M 1.14B 92.23M 90.27M 3.94B |
| Net Debt | 4.4M 3.8M 3.5M 3.27M 6.14M 418M 6.23M 41.3M 16.1M 203M 16.49M 16.14M 704M | -1.32M -1.14M -1.05M -985K -1.85M -126M -1.87M -12.42M -4.84M -61.16M -4.96M -4.86M -212M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/06/26 | 1.600 $ | -3.03% | 4,488 |
| 11/06/26 | 1.650 $ | -6.41% | 2,633 |
| 10/06/26 | 1.763 $ | +1.32% | 7,264 |
| 09/06/26 | 1.740 $ | +3.57% | 6,642 |
| 08/06/26 | 1.680 $ | +0.60% | 1,854 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXG Stock
Select your edition
All financial news and data tailored to specific country editions
